#EuropeanCommission Grants Marketing Authorisation for #DARZALEX®▼(#Daratumumab) Subcutaneous Formulation for all Currently Approved #Daratumumab Intravenous Formulation Indications $JNJ https://t.co/10m4VmgXAf